Samuel D. Oberdick

Email: samuel.oberdick@nist.gov 
Phone: 303-497-3054

Curriculum Vitae
Google Scholar Profile 

Education

PhD, Physics, Carnegie Mellon University (2016)
BA, Physics, University of Chicago (2010)

About

Head shot.I am an experimental physicist and a research associate at the National Institute of Standards and Technology (NIST) where I work with the Magnetic Imaging Group (MIG). I am also a research associate with the Department of Physics at CU Boulder. My research is focused on the intersection of magnetic nanotechnology, biosensing and medical imaging. 

I received my BA in Physics (with honors) from The University of Chicago in 2010 and a PhD in Physics from Carnegie Mellon University in 2016. At Carnegie Mellon, I performed my PhD work in Professor Sara Majetich's group and wrote my dissertation on patterned magnetic nanostructures.

Following my PhD, I was awarded a National Research Council (NRC) Postdoctoral Fellowship. I performed my NRC fellowship at NIST, Boulder, where I was advised by Dr. Gary Zabow. During my postdoc, I researched novel MRI contrast agents and magnetic signal transduction in magnetic nanoparticle/polymer composites.

Currently, I am interested in using magnetic signals to learn about biological and soft matter systems. To learn more about my work, please visit the "Research" page. 

News

4/18/2024: NIST published a spotlight on our shape-shifting MRI probes. Link.

12/20/2023: NIST published a story describing our recent work on micromolded shape-shifting MRI contrast agents. Read the story here.

12/19/2023: My paper on using shaped magnetogel microparticles for multispectral MRI contrast and sensing has been published in ACS Sensors. Link.

9/7/2023: Physics World published an article describing the low-field MRI research done by my group at NIST. Ready the story here.

7/17/2023: NIST published a story highlighting the research on low-field MRI performed by the Magnetic Imaging Group. Read the story here.

7/17/2023: My paper on using iron oxide nanoparticles as T1 contrast agents for low-field MRI has been published in Scientific Reports. Link.

7/6/2023: NIST published a spotlight on MRI contrast agent research. Link.